Proper storage of biological assets is vital to keep your research moving forward. Yet, while you focus on research activities, it’s all too common for sample and critical reagent inventories to morph into an unorganized sprawl. The most obvious impact is time spent finding your materials of interest, but there are other consequences to sample […]
View Blog
A Strategic Guide for U.S. Pharmaceutical Manufacturers As more pharmaceutical companies bring drug manufacturing stateside, a critical but often under-planned question arises: what happens to your product after it leaves the manufacturing floor? For products requiring strict temperature control and regulatory compliance, storage isn’t just about holding space. It’s about protecting product integrity, meeting regulatory […]
View Blog
Azenta Life Sciences has officially opened its state-of-the-art biorepository facility in the Greater Boston area, designed to serve the unique storage and management needs of the biotech and life sciences industries. Located strategically to support Cambridge and Boston’s vibrant community of biotech and pharmaceutical companies, the facility offers advanced sample storage and handling capabilities, helping […]
View Blog
Part 1 of a three-part series on cryo cold chain management for cell and gene therapies With a projected rate of 10-20 product approvals per year, the global cell and gene therapy (CGT) industry is rapidly evolving. The clinical pipeline delivers a promise to the patient population with unmet medical needs ranging from oncology to […]
View Blog
Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago during a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest laboratory, nestled among numerous cryogenic freezers within a section of the building inaccessible to anyone involved in the original research. The samples intermingle […]
View Blog
The field of cell and gene therapy (CGT) is experiencing an exciting transformation, marked by the recent FDA approval for the first CRISPR-based sickle cell treatment. As the CGT landscape rapidly expands, it’s important for stakeholders to address the challenges of scalability head-on. Cryopreservation emerges as a critical yet understated element in the scalability equation, essential for […]
View Blog
The ever-expanding horizon of medical research and healthcare delivery owes a significant debt to the technological advancements that have shaped the industry. Among the many innovations, cryopreservation stands out as a pivotal technique that preserves the integrity and functionality of biological specimens over extended periods. By freezing cells, tissues, and even whole organs at sub-zero […]
View Blog
Recap of an Interview with David Lewandowski, Azenta Life Sciences, and Carol Houts, Chief Strategy Officer at Germfree, in partnership with Phacilitate The cutting-edge domain of cell and gene therapies is undergoing a remarkable transformation, with innovative technologies and groundbreaking treatments promising to revolutionize healthcare. However, as these therapies continue to advance, so do the challenges surrounding […]
View Blog
Automation plays a vital role in the manufacturing process of advanced therapies, yet the cold chain infrastructure has often been overlooked. While automated solutions are sometimes perceived as expensive alternatives, recent studies have demonstrated the tangible benefits of automating cold chain processes, including time efficiencies and improved process rigor. This article explores a study conducted […]
View Blog
An Interview with Cryobiology Expert Dr. Jason Acker Freezing is stressful for mammalian cells – to say the least. Cells face potentially dangerous ice crystals and severe dehydration when cooled to very low temperatures. Yet, by carefully configuring a cryopreservation protocol, cells can be shielded from injury. Thanks to discoveries in cryobiology, scientists have preserved […]
View Blog